Elizabeth Feltner, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5 Land Re Way, Suite 100, Spencerport, NY 14559 Phone: 585-368-6620 Fax: 585-368-6621 |
Marina K S Ma, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Land Re Way, Suite 100, Spencerport, NY 14559 Phone: 585-368-6620 |
Elizabeth K Gagnier, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Land Re Way Ste 100, Spencerport, NY 14559 Phone: 585-368-6620 Fax: 585-368-6621 |
Brett Edward Kemp, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 42 Nichols St Ste 10, Spencerport, NY 14559 Phone: 585-637-7558 Fax: 585-637-7566 |
Patrick Mcgrath, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Land Re Way, Suite 100, Spencerport, NY 14559 Phone: 585-368-6620 Fax: 585-368-6621 |
Melanie Conolly, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Land Re Way, Suite 100, Spencerport, NY 14559 Phone: 585-368-6620 Fax: 585-368-6621 |
News Archive
A white paper, How is a Shortage of Primary Care Physicians Affecting the Quality and Cost of Medical Care? , released today by the American College of Physicians (ACP) documents the value of primary care by reviewing 20 years of research.
Threshold Pharmaceuticals, Inc. today announced updated Phase 1/2 clinical trial results related to the Company's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the ASCO Gastro Intestinal Cancers Symposium that took place in San Francisco from January 20-22, 2011.
To focus a much-needed, objective light on the ethical concerns regarding the national debate on healthcare reform, the LIFE Institute of Rainbow Hospice and Palliative Care will be hosting a public forum on "Ethics and Healthcare Reform" on Tuesday, November 17th at 7 p.m. at Edison Park Lutheran Church, 6626 N. Oliphant Ave., Chicago.
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.
› Verified 9 days ago